IMM 1.56% 31.5¢ immutep limited

Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 14 Posts.
    lightbulb Created with Sketch. 7
    Yes Phil we are making something more profound than widgets. Great results for Pembro+ EFTI in the PD-L1(low) patients, and a general benefit (ORR) for all patients. Message to Fredrick and team - just keep doing what you have been doing - "keep your head down and bum up" because its gunna make a difference to peoples lives.
    https://hotcopper.com.au/data/attachments/4408/4408806-a00d73461e6cb74184191efb83f55778.jpg

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.